New Issue: Bio-Rad Laboratories sells $200 million 10-year notes at par to yield 6 1/8%

By Paul A. Harris

St. Louis, Dec. 13 - Bio-Rad Laboratories Inc. priced a quick-to-market $200 million issue of 10-year senior subordinated notes (Ba3/BB-) at par to yield 6 1/8% Monday, according to an informed source.

Price talk was 6 1/8% to 6¼%.

Credit Suisse First Boston ran the books for the Rule 144A/Regulation S issue.

Proceeds will be used for working capital and for general corporate purposes, which may include acquisitions.

Bio-Rad Laboratories is a Hercules, Calif.-based manufacturer and distributor of life science research products and clinical diagnostics.

Issuer:	Bio-Rad Laboratories Inc.
Amount:	$200 million
Maturity:	Dec. 15, 2014
Security description:	Senior subordinated notes
Bookrunner:	Credit Suisse First Boston
Coupon:	6 1/8%
Price:	Par
Yield:	6 1/8%
Spread:	197 basis points
Call features:	Make-whole call at Treasuries plus 75 basis points until Dec. 15, 2009, then callable at 103.063, 102.042, 101.021 and par on and after Dec. 15, 2012
Equity clawback:	Until Dec. 15, 2007 for 35% at 106.125
Trade date:	Dec. 13
Settlement date:	Dec. 21
Ratings:	Moody's: Ba3
	Standard & Poor's: BB-
Price talk:	6 1/8%-6¼%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.